Table 1 Demographic characteristics of the participants by dose age groups
Characteristic | 10 µg group | 25 µg group | 50 µg group | Overall |
|---|---|---|---|---|
Adults (aged 18–55 yr) | N = 12 | N = 12 | N = 12 | N = 36 |
Sex-number (%) | ||||
Female | 9 (75.0) | 7 (58.3) | 8 (66.7) | 24 (66.7) |
Age-Mean (s.d.) | 35.9 (5.9) | 34.1 (9.0) | 37.3 (11.8) | 35.8 (9.1) |
Min–max | 21–44 | 26–53 | 21–53 | 21–53 |
Body mass index (kg m−2), Mean (s.d.) | 23.9(3.3) | 22.1(2.6) | 22.9 (2.5) | 23.0 (2.8) |
Elderly (aged 56–75 yr) | N = 12 | N = 12 | N = 12 | N = 36 |
Sex-number (%) | ||||
Female | 7 (58.3) | 7 (58.3) | 5 (41.7) | 19 (52.8) |
Age-Mean (s.d.) | 67.4 (3.2) | 67.8 (3.2) | 60 (5.5) | 65.1 (5.4) |
Min–max | 64–73 | 65–74 | 56–71 | 56–74 |
Body mass index (kg m−2), Mean (s.d.) | 24.1 (4.2) | 22.7 (3.1) | 23.2 (2.5) | 23.3 (3.3) |
